Quantcast

Latest Drug design Stories

2014-09-17 16:27:36

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 /PRNewswire/ -- The In Silico Drug Discovery Conference today announced speakers and presentation topics that will be featured at the conference, which takes place at North Carolina Biotechnology Center's Hamner Conference Center on December 3 and 4, 2014. Researchers, students, drug developers, business development professionals, and biotechnology managers are invited to hear the following: KEYNOTE SPEAKERS Ruben Abagyan, PhD UC San Diego Skaggs...

2014-09-02 16:22:29

NEW YORK, Sept. 2, 2014 /PRNewswire-USNewswire/ -- The cover story of the September 2014 edition of Chemical and Engineering News, titled "Aiming for HIV's Weak Spot," cites work by NYBC's Asim Debnath, Ph.D., and his Laboratory of Molecular Modeling and Drug Design for their work to identify small molecules that prevent HIV from entering T cells. Here's a link to the story: http://cen.acs.org/articles/92/i35/Aiming-HIVs-Weak-Spot.html Dr. Debnath's lab was the first to discover the...

2014-07-29 08:32:54

Phase I Project to Focus on Advanced Molecular Search Models for the Inverse Design Computational Drug Discovery Platform RESEARCH TRIANGLE PARK, N.C., July 29, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. The grant is valued at $150,000. Cloud...

2014-07-14 20:20:55

Dehydrons are defects in protein structure that promote protein associations. Scientist Ariel Fernandez Stigliano recently showed that they are also endowed with chemical functionality, enabling and stimulating enzyme catalysis. The discovery may have paramount implications for biomedical engineering, catalysis optimization and epistructure-based drug design. HOUSTON and BUENOS AIRES, Argentina, July 14, 2014 /PRNewswire/ -- Ariel Fernandez Consultancy serves the biotechnology...

2014-07-14 12:27:06

Researchers to Use IBM Blue Gene/Q Supercomputer for Computational Drug Design and Discovery RESEARCH TRIANGLE PARK, N.C., July 14, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today the expansion of its drug design and development program. The company has been granted supercomputing time at Argonne National Laboratory to design inhibitors of multiple parasitic targets. Through a...

2014-07-11 11:03:07

DOE/SLAC National Accelerator Laboratory SLAC, Stanford advance will benefit thousands of computational studies in wide range of fields Scientists at Stanford University and the Department of Energy's SLAC National Accelerator Laboratory have found a way to estimate uncertainties in computer calculations that are widely used to speed the search for new materials for industry, electronics, energy, drug design and a host of other applications. The technique, reported in the July 11 issue...

2014-06-12 08:29:58

New name better reflects company's cloud-based approach to drug design and development RESEARCH TRIANGLE PARK, N.C., June 12, 2014 /PRNewswire/ -- TeraDiscoveries, Inc., a bio-therapeutics company focused on cloud-based drug design and development, announced today that effective immediately, it has changed its corporate name to Cloud Pharmaceuticals, Inc. Cloud Pharmaceuticals designs new drugs and drug candidates and accelerates the development process by implementing new,...

2014-05-15 04:22:26

LONDON and BOSTON, May 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that Fiona Marshall, Heptares' Chief Scientific Officer and co-founder, will give a company presentation at the UBS Global Healthcare Conference [https://www.ubs.com/global/en/investment-bank/key-investor-conferences/americas.html ] in New York City, NY, USA. The presentation will take place at 9:00am EDT on Monday 19 May....

2014-03-25 23:25:20

In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. http://www.marketsandmarkets.com/Market-Reports/latin-american-bioinformatics-market-2908323.html (PRWEB) March 25, 2014 The “Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) &...

2014-02-13 12:27:40

MILLBROOK, N.Y., Feb. 13, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Adam J. Stein, Ph.D. to its Scientific Advisory Committee. Dr. Stein has over eighteen years of experience in structural biology, with the last seven in applying structural biology and biophysical chemistry to the drug discovery efforts in biotech. While at deCODE Genetics, he was able to design fragment libraries that enabled us to elucidate...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related